British Columbia < Bromocriptine < Bronchi

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 48.
[0-20] [0 - 20][0 - 48][20-40]

Ident.	Authors (with country if any)	Title
001373 (2011)	Louis C S. Tan ; Kenneth K C. Ng ; Wing-Lok Au ; Raymond K K. Lee ; Nigel C K. Tan	Bromocriptine use and myocardial function.
001A88 (2009)	Tomoyuki Uchiyama [Japon] ; Ryuji Sakakibara ; Tatsuya Yamamoto ; Takashi Ito ; Chiharu Yamaguchi ; Yusuke Awa ; Masashi Yano ; Mitsuru Yanagisawa ; Makoto Kobayashi ; Yoshinori Higuchi ; Tomohiko Ichikawa ; Tomonori Yamanishi ; Takamichi Hattori ; Satoshi Kuwabara	Comparing bromocriptine effects with levodopa effects on bladder function in Parkinson's disease.
001E59 (2009)	Frank Andersohn [Allemagne] ; Edeltraut Garbe	Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
001F38 (2009)	Louis C S. Tan [Singapour] ; Kenneth K C. Ng ; Wing-Lok Au ; Raymond K K. Lee ; Yiong-Huak Chan ; Nigel C K. Tan	Bromocriptine use and the risk of valvular heart disease.
002260 (2008)	Kazuo Yamashiro [Japon] ; Miki Komine-Kobayashi ; Taku Hatano ; Takao Urabe ; Hideki Mochizuki ; Nobutaka Hattori ; Yoshitaka Iwama ; Hiroyuki Daida ; Michi Sakai ; Takeo Nakayama ; Yoshikuni Mizuno	The frequency of cardiac valvular regurgitation in Parkinson's disease.
002730 (2007)	Jonas Lindh	Short episode of seizures in a newborn of a mother treated with levodopa/carbidopa/entacapone and bromocriptine.
002C47 (2006)	Ji-Youn Kim [Corée du Sud] ; Eun Joo Chung ; Seung Woo Park ; Won Yong Lee	Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists.
002E03 (2006)	Alexandre Castro-Caldas [Portugal] ; Paul Delwaide ; Wolfgang Jost ; Marcelo Merello ; Adrian Williams ; Paolo Lamberti ; Miguel Aguilar ; Susanna Del Signore ; Pierre Cesaro	The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease.
003084 (2005)	Christopher G. Goetz [États-Unis] ; Werner Poewe ; Olivier Rascol ; Cristina Sampaio	Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
003190 (2005)	Peter H. Kraus [Allemagne] ; Peter Klotz ; Arndt Hoffmann ; Johannes Lewe ; Horst Przuntek	Analysis of the course of Parkinson's disease under dopaminergic therapy: performance of "fast tapping" is not a suitable parameter.
003205 (2005)	Mariese A. Hely [Australie] ; John G L. Morris ; Wayne G J. Reid ; Robert Trafficante	Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.
003210 (2004)	K Ray Chaudhuri ; Vandena Dhawan ; Sumit Basu ; Gordon Jackson ; Per Odin	Valvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non-ergot agonists may also not be spared.
003321 (2004)	Katherine Grosset [Royaume-Uni] ; Fiona Needleman ; Graeme Macphee ; Donald Grosset	Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
003667 (2003)	Yoshikuni Mizuno [Japon] ; Nobuo Yanagisawa ; Sadako Kuno ; Mitsutoshi Yamamoto ; Kazuko Hasegawa ; Hideki Origasa ; Hisayuki Kowa	Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease.
003956 (2002)	Robert A. Hauser [États-Unis] ; Nicholas H G. Holford	Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease.
003980 (2002)		DA agonists -- ergot derivatives: pergolide: management of Parkinson's disease.
003984 (2002)		DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
003D40 (2001)	J L Montastruc [France] ; K. Desboeuf ; M. Lapeyre-Mestre ; J M Senard ; O. Rascol ; C. Brefel-Courbon	Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.
003F79 (2000)	R A Hauser [États-Unis] ; W C Koller ; J P Hubble ; T. Malapira ; K. Busenbark ; C W Olanow	Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
004061 (2000)	C. Ramaker [Pays-Bas] ; W J Van De Beek ; M J Finken ; B J Van Hilten	The efficacy and safety of adjunct bromocriptine therapy for levodopa-induced motor complications: a systematic review.
004137 (1999)	J L Montastruc [France] ; O. Rascol ; J M Senard	Treatment of Parkinson's disease should begin with a dopamine agonist.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Bromocriptine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Bromocriptine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Bromocriptine
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024